Author

Peter J. Atkinson

Eisai (United Kingdom)ORCID 0000-0003-3757-9389Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1 Assay:protein structure· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Alan R. PrescottiD· 1 shared Aleksandra Szykowska· 1 shared Alex N. BullockiD· 1 shared Carol A. Routledge· 1 shared Charlotta PregeriD· 1 shared Debra L. Taylor· 1 shared Diego Gómez‐NicolaiD· 1 shared Dongming QianiD· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alan R. PrescottORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyStructurePeer-reviewedJul 6, 2021

Selection and structural characterisation of anti-TREM2 scFvs that reduce levels of shed ectodomain

Aleksandra Szykowska, Yu Chen, Thomas B. Smith…·Alex N. Bullock

The paper identifies and characterizes anti-TREM2 scFv antibodies that inhibit soluble TREM2 production.

19 citations

humanprotein structure

𝕏 PostBluesky

NeuroscienceFrontiers in ImmunologyPeer-reviewedOct 8, 2020

Inhibition of IL34 unveils tissue-selectivity and is sufficient to reduce microglial proliferation in chronic neurodegeneration

Juliane Obst, Emilie Simon, María Martín‐Estebané…·Diego Gómez‐Nicola

This study evaluates IL-34 inhibition as a strategy to reduce microglial proliferation in prion disease, showing tissue-selectivity and reduced side effects compared to CSF1R inhibition.

33 citations

mouseexperimental assay

𝕏 PostBluesky